RxSavings.org
August 15, 2010 by Rx Times
Filed under Rx Products & Services Showcase
About the RxSavings.org Discount Prescription Drug Plan
What is a Discount Prescription Drug Plan?
The discount plan provides members significant savings through the use of their provided Discount Prescription Drug Card. At the point of sale, members simply present their card at a participating pharmacy and their discount is instantly applied. It’s that easy!
What is a Discount [...]
Midway College School of Pharmacy Announces Leadership Team Members
Paintsville, Ky. -Midway College School of Pharmacy is pleased to announce the following members of its leadership team.
Lanny E. Foss, PhD
Founding Dean
Barry Bleidt, PhD, PharmD, RPh
Senior Associate Dean for Academic Affairs
Emily Coleman, MEd
Assistant Dean for Student Affairs
Patricia E. Johnson, RPh
Director of Experiential Education
Ajoy Koomer, PhD, EMBA
Director of Assessment
David Matthews, PharmD, RPh, CGP
Chair of Pharmacy Practice and Assistant [...]
U.S. District Court Rules Against Lilly Regarding Strattera Patent
INDIANAPOLIS, Aug 12, 2010 -Eli Lilly and Company (NYSE: LLY) today announced that the U.S. District Court for the District of New Jersey has ruled against the company in its patent litigation for Strattera(R) (atomoxetine). In the case of Eli Lilly and Company v. Actavis Elizabeth LLC, et al, the court ruled that Lilly’s ‘590 [...]
*NEW*Answer for your chance to receive a FREE RxTimes travel coffee mug!
May 21, 2010 by Rx Times
Filed under Rx Quiz Question of the Week
What is the minimum APACHE II scored needed in order to initiate Xigris (Drotrecogin Alfa) therapy in an adult patient with severe sepsis?
Send your answer to stephen.grosch@rxtimes.com for a chance to be selected to receive a free RxTimes Magazine travel coffee mug!
Only confirmed subscribers are eligible. Please subscribe to [...]
McNeil Consumer Healthcare Announces Voluntary Recall of Certain OTC Infants’ and Children’s Products
Fort Washington, PA (April 30, 2010) – McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., in consultation with the U.S. Food and Drug Administration (FDA), is voluntarily recalling all lots that have not yet expired of certain over-the-counter (OTC) Children’s and Infants’ liquid products manufactured in the United States and distributed in the United States, Canada, [...]
Rite Aid Reports 1.0 Percent Same Store Sales Decrease for April
CAMP HILL, Pa.–(BUSINESS WIRE)–Rite Aid Corporation (NYSE:RAD) today announced sales results for April.
Monthly Sales
For the four weeks ended April 24, 2010, same store sales decreased 1.0 percent over the prior-year period. April front-end same stores sales decreased 1.2 percent while pharmacy same store sales, which included an approximate 103 basis points negative impact from new [...]
Despite Concern, Americans Aren’t Protecting Themselves Against Diabetes
COLUMBUS, Ohio, April 28, 2010 - Diabetes affects more than 23 million people in the United States today and another 54 million people have pre-diabetes, according to the Centers for Disease Control and Prevention (CDC). However, while nearly 60 percent of Americans are concerned about developing diabetes, many aren’t taking the necessary steps to protect their [...]
Abbott Receives FDA Approval for Once-Daily Dosing of Kaletra (R) (lopinavir / ritonavir) for Treatment-Experienced Patients
ABBOTT PARK, Ill., April 28, 2010 - Abbott announced today that the U.S. Food and Drug Administration (FDA) approved once-daily dosing of Kaletra(R) (lopinavir/ritonavir) for adult patients with HIV who have previously taken antiretroviral therapy. Kaletra once-daily dosing is already indicated for adult patients new to antiretroviral treatment. This gives treatment-experienced patients who have HIV that [...]
Therigy Signs Extensive Services Agreement with Henry Ford Health Systems
ORLANDO, FL – Therigy, LLC announced today it has been contracted by Henry Ford Health Systems (HFHS) to provide an array of services, including designing its new facility and developing a best-in-class operation with an integrated therapy management solution to provide a higher level of care for specialty pharmacy patients.
“Therigy is excited to be chosen to [...]
Nycomed and Merck & Co., Inc., Announce Commercialization Agreements For Daxas® in Europe and Canada
ZURICH & WHITEHOUSE STATION, N.J.–(BUSINESS WIRE)–Nycomed and Merck & Co., Inc. (based in Whitehouse Station, New Jersey and known as MSD outside the USA and Canada) today announced that they have entered into a co-promotion agreement for Canada and certain European countries for the commercialization of Daxas® (roflumilast), an investigational once-daily tablet for patients with [...]
